These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34119332)

  • 21. Immunological responses in acute low-tone sensorineural hearing loss and Ménière's disease.
    Fuse T; Hayashi T; Oota N; Fukase S; Asano S; Kato T; Aoyagi M
    Acta Otolaryngol; 2003 Jan; 123(1):26-31. PubMed ID: 12625569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of autoimmune sensorineural hearing loss after endolymphatic sac decompression: two case reports.
    Ochoa VM; Weider DJ
    Otol Neurotol; 2003 Mar; 24(2):279-82. PubMed ID: 12621344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inner ear hearing loss--predisposing factor in acute disorders of inner ear function (sudden deafness and vestibular loss)?].
    Weinaug P
    HNO; 1985 Dec; 33(12):561-3. PubMed ID: 4086349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in viral inner ear disorders.
    Beyea JA; Agrawal SK; Parnes LS
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):404-8. PubMed ID: 22902415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Correlation of Clinical Corticosteroid Responsiveness With Expression of IL-6 in Peripheral Blood Immune Cells (PBMC) in Patients With Autoimmune Inner Ear Disease (AIED).
    Gorthey SW; Pathak S; Vambutas A
    Otol Neurotol; 2021 Oct; 42(9):1422-1428. PubMed ID: 34028401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atmospheric pressure on hearing in patients with Menière's disease.
    Kitahara M; Kodama A; Izukura H; Ozawa H
    Acta Otolaryngol Suppl; 1994; 510():111-2. PubMed ID: 8128864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of interleukin-1 gene polymorphisms with sudden sensorineural hearing loss and Ménière's disease.
    Furuta T; Teranishi M; Uchida Y; Nishio N; Kato K; Otake H; Yoshida T; Tagaya M; Suzuki H; Sugiura M; Sone M; Hiramatsu M; Sugiura S; Ando F; Shimokata H; Nakashima T
    Int J Immunogenet; 2011 Jun; 38(3):249-54. PubMed ID: 21385326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune-Mediated Inner Ear Disease: Diagnostic and therapeutic approaches.
    Penêda JF; Lima NB; Monteiro F; Silva JV; Gama R; Condé A
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(2):97-104. PubMed ID: 29525415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The importance of IgG auto-antibodies, anti-collagen type II specific in Menière's disease and progressive hearing loss].
    Muiño JC; Carreras R; Ocampo MA; Ferrero M; Romero Piffiguer MD; Landa C; Beltramo D
    Rev Fac Cien Med Univ Nac Cordoba; 1999; 56(2):71-80. PubMed ID: 10883508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS; Meyerhoff WE; Cohen SB
    Semin Arthritis Rheum; 2004 Oct; 34(2):544-8. PubMed ID: 15505770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden sensorineural hearing loss: supporting the immunologic theory.
    Berrocal JR; Ramírez-Camacho R
    Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):989-97. PubMed ID: 12450172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Binding of serum immunoglobulins to human inner ear tissue in inner ear hearing loss: methodologic limits].
    Gebbers JO; Altermatt HJ; Arnold W; Laissue JA; Pfaltz CR
    HNO; 1987 Dec; 35(12):487-91. PubMed ID: 3323147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calculated versus measured pure tone bone conduction 3 kHz thresholds in sudden sensorineural hearing loss.
    Shilo S; Ziv-Baran T; Oron Y; Handzel O; Cavel O; Eta RA; Muhanna N; Ungar OJ
    J Laryngol Otol; 2021 Sep; 135(9):820-824. PubMed ID: 34308808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensorineural hearing loss of suspected autoimmune etiology: a report of three cases.
    Kataoka H; Takeda T; Nakatani H; Saito H
    Auris Nasus Larynx; 1995; 22(1):53-8. PubMed ID: 7677637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance-based volumetric measurement of the endolymphatic space in patients with Meniere's disease and other endolymphatic hydrops-related diseases.
    Inui H; Sakamoto T; Ito T; Kitahara T
    Auris Nasus Larynx; 2019 Aug; 46(4):493-497. PubMed ID: 30503567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients.
    Pathak S; Stern C; Vambutas A
    Immunol Res; 2015 Dec; 63(1-3):236-45. PubMed ID: 26392121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.